In all honesty, Joe is just harping on the same th
Post# of 36537
(Total Views: 255)
Posted On: 08/04/2020 10:17:55 AM
Re: Zolis_onkel #19275
In all honesty, Joe is just harping on the same things in every PR. There is not anything new he is saying and that's another reason why the PPS is still going down.
I started this journey a year ago in June and I have literally seen misstep after misstep from Joe on taking Generex / NGIO forward time and time again. The PRs keep proving it. They seem recycled information from one to another with some added information as time goes on, but generic and a bunch of errors.
Covid can be blamed for a lot of things. Errors are not part of Covid. That's on bad attention to details. Doing the blame game and not taking responsibility, well, that is not a Covid problem, that's a management issue. Not responding to the SEC on time. Again, that's on management.
We just had a CC that was kind of a letdown. Based on this PR as well as the the last one concerning the two CCs for Generex and NGIO, I am not expecting any earth shattering news to come out of either.
We have PRs about CCs coming in 3 weeks, but we get nothing in PRs about any real developments happening with trials, with testing, with nothing actually concrete. We need real news coming out. Not CCs that tell us nothing and fall flat making us leave with more questions than not.
I started this journey a year ago in June and I have literally seen misstep after misstep from Joe on taking Generex / NGIO forward time and time again. The PRs keep proving it. They seem recycled information from one to another with some added information as time goes on, but generic and a bunch of errors.
Covid can be blamed for a lot of things. Errors are not part of Covid. That's on bad attention to details. Doing the blame game and not taking responsibility, well, that is not a Covid problem, that's a management issue. Not responding to the SEC on time. Again, that's on management.
We just had a CC that was kind of a letdown. Based on this PR as well as the the last one concerning the two CCs for Generex and NGIO, I am not expecting any earth shattering news to come out of either.
We have PRs about CCs coming in 3 weeks, but we get nothing in PRs about any real developments happening with trials, with testing, with nothing actually concrete. We need real news coming out. Not CCs that tell us nothing and fall flat making us leave with more questions than not.
(2)
(1)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼